The trading price of Elevai Labs Inc (NASDAQ:ELAB) floating lower at last check on current market day and closing at $0.02, -4.80% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $0.021 and $0.0222. In examining the 52-week price action we see that the stock hit a 52-week high of $4.24 and a 52-week low of $0.02. Over the past month, the stock has lost -77.98% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elevai Labs Inc, whose market valuation is $11.28 million at the time of this writing, is expected to release its quarterly earnings report in December. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest ELAB has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that ELAB’s price is currently -52.94% off the SMA20 and -80.29% off the SMA50. The RSI metric on the 14-day chart is currently showing 27.14, and weekly volatility stands at 37.90%. When measured over the past 30 days, the indicator reaches 29.19%. Elevai Labs Inc (NASDAQ:ELAB)’s beta value is currently sitting at -0.34, while the Average True Range indicator is currently displaying 0.01.
To see how Elevai Labs Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: ELAB stock’s performance was -4.80% in the latest trading.
An evaluation of the daily trading volume of Elevai Labs Inc (NASDAQ:ELAB) indicates that the 3-month average is 106.75 million. However, this figure has increased over the past 10 days to an average of 487.73.
Currently, records show that 49.38 million of the company’s shares remain outstanding. The insiders hold 20.30% of outstanding shares, whereas institutions hold 15.10%. The stats also highlight that short interest as of 2024-10-31, stood at 9.42 million shares, resulting in a short ratio of 0.17 at that time. From this, we can conclude that short interest is 2228.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 0.69 million. However, since the stock’s price has seen -98.81% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
